|
|
preandiloid_A + acceptor <=> preandiloid_B + reduced_acceptor
|
1.1.99
|
–
|
| |
MetaCyc:
RXN-16084
|
|
|
|
preandiloid_B + acceptor <=> preandiloid_C + reduced_acceptor
|
1.1.99
|
–
|
| |
MetaCyc:
RXN-16085
|
|
|
|
5,7-dihydroxy-4,6-dimethylphthalide + (2E,6E)-farnesyl_diphosphate <=> farnesyl-5,7-dihydroxy-4,6-dimethylphthalide + diphosphate
|
2.5.1
|
–
|
| |
MetaCyc:
RXN-16078
|
|
|
|
acetyl-andilesin_A <=> andilesin_B + acetate + H+
|
not assigned
|
–
|
| |
MetaCyc:
RXN-16091
|
|
|
|
farnesyl-5,7-dihydroxy-4,6-dimethylphthalide + O2 + reduced_acceptor <=> epoxyfarnesyl-5,7-dihydroxy-4,6-dimethylphthalide + H2O + acceptor
|
1.14.13
|
–
|
| |
MetaCyc:
RXN-16080
|
|
|
|
andilesin_A + acceptor <=> andilesin_D + reduced_acceptor
|
1.1.99
|
–
|
| |
MetaCyc:
RXN-16088
|
|
|
|
andiconin + O2 + NADPH + H+ <=> andilesin_D + NADP+ + H2O
|
1.14.13
|
–
|
| |
MetaCyc:
RXN-16087
|
|
|
|
preandiloid_C + 2-oxoglutarate + ascorbate + O2 <=> andiconin + succinate + CO2 + dehydroascorbate + H2O
|
1.14.20
|
–
|
| |
MetaCyc:
RXN-16086
|
|
|
|
4,6-dihydroxy-2-(hydroxymethyl)-3,5-dimethylbenzoate + H+ <=> 5,7-dihydroxy-4,6-dimethylphthalide + H2O
|
3.1.1
|
–
|
| |
MetaCyc:
RXN-16074
|
|
|
|
epoxyfarnesyl-5,7-dihydroxy-4,6-dimethylphthalide <=> preandiloid_A
|
5.4.99
|
–
|
| |
MetaCyc:
RXN-16083
|
|
|
|
3,5-dimethylorsellinate + O2 + reduced_acceptor <=> 4,6-dihydroxy-2-(hydroxymethyl)-3,5-dimethylbenzoate + H2O + acceptor
|
1.14.99
|
–
|
| |
MetaCyc:
RXN-16073
|
|
|
|
andilesin_C + 2-oxoglutarate + O2 <=> anditomin + succinate + CO2 + H2O
|
1.14.20
|
–
|
| |
MetaCyc:
RXN-16093
|
|
|
|
andilesin_B + reduced_acceptor <=> andilesin_C + acceptor
|
1.1.99
|
–
|
| |
MetaCyc:
RXN-16092
|
|
|
|
S-adenosyl-L-methionine + acetyl-CoA + malonyl-CoA <=> 3,5-dimethylorsellinate + S-adenosyl-L-homocysteine + CO2 + CoA
|
2.3.1
|
–
|
| |
MetaCyc:
RXN-16072
|
|
|
|
andilesin_A + acetyl-CoA <=> acetyl-andilesin_A + CoA
|
2.3.1
|
–
|
| |
MetaCyc:
RXN-16090
|
|
